Introduction
Opened 1 November 2026, Novo Nordisk lists Ozempic pen self-pay at $199 a month for two fills, then $349 a month, and $499 a month at 2 mg. Gala Health lists the same brand from $1,299 a month cash, and the RxSpan MD API lists 1299 with no billing period on that row.
Embody is a telehealth provider, not the drug: its compounded semaglutide JSON shows a $79 sale and a $299 regular price, with no selling plan. The sale is not the continuing price, and it is not an Ozempic pen.
A drug on one side, a provider on the other
Ozempic versus Embody is an easy phrase and a mismatched pair. Ozempic is Novo Nordisk's semaglutide product. Embody is a telehealth provider whose one-month GLP-1 products are titled compounded semaglutide and compounded tirzepatide. A budget that puts $79 next to $1,299 is putting a compounded sale next to a telehealth brand card, and neither of those is the only Ozempic figure.
The useful split is the one in the table. Manufacturer self-pay, telehealth brand cash, and Embody's compounded one-month price stay in different rows.
| Purchase | What it is | Cash figure |
|---|---|---|
| Ozempic pen, NovoCare | Novo Nordisk self-pay for the pen | $199 for two fills of 0.25 mg and 0.5 mg through 31 December 2026, then $349 a month, and $499 a month at 2 mg |
| Ozempic, Gala Health | Telehealth cash card for the brand | From $1,299/month, cash price. Insurance may reduce it |
| Ozempic, RxSpan MD | Public product API row | 1299, with no billing period on the row |
| Embody compounded semaglutide compounded (not FDA-approved) | One-month compounded supply compounded (not FDA-approved) | Sale $79, regular $299. No selling plan. The sale is not the continuing price |
We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure
LIVE CATALOGOzempic and compounded semaglutide prices on record
Some provider links below are affiliate links. If you start a program through one, Telehealth Ledger may earn a commission at no extra cost to you. Commissions do not change this order.
Catalog rows for the Ozempic pen and for compounded semaglutide. Embody's sale and regular price are both on the compounded row. NovoCare's ladder is the manufacturer page, not a row in this module unless a provider has published its own Ozempic price.
| Provider | Published price | What is included |
|---|---|---|
| #1 Gala Health | $1,299, checked 27 October 2026 a month, continuing Visit provider Affiliate link · we may earn a commission | Ozempic® · Weekly injection · medication included The Ozempic product page says From $1,299/month, cash price. It says insurance may reduce the cost. That page shows no other dollar price. Price source · checked 27 October 2026 |
| #2 RxSpan MD | $1,299, checked 26 October 2026 a month, continuing Visit provider Affiliate link · we may earn a commission | Ozempic® · Weekly branded injection · medication included Checked 26 October 2026. The public product API still lists Ozempic® at 1299 and does not print a billing period on that row. The stored monthly figure stays; it is not a new price. Price source · checked 26 October 2026 |
- DrHouse: $129 self-pay visit or insurance copayLast checked 21 Oct 2026Medication or membership billed separately
- MEDGm: $171 membership + medication cost (medication total not published)Medication or membership billed separately
- Shed Rx: Starting at $599/mo. Hero $149 is CMS template bleed.Last checked 14 Sept 2026Medication included as published
| Provider | Published price | What is included |
|---|---|---|
| #1 CoreAge Rx | $79compounded (not FDA-approved), checked 26 October 2026 a month, paying $948 for 12 months up front Visit provider Affiliate link · we may earn a commission | Compounded semaglutide injection · Injection · medication includedPrice source · checked 26 October 2026 |
| #2 yourEra | $89compounded (not FDA-approved), checked 26 October 2026 a month, continuing Visit provider Affiliate link · we may earn a commission | Compounded Semaglutide month-to-month · Weekly subcutaneous injection; month-to-month · medication included Checked 25 October 2026. Month-to-month semaglutide is $89/mo after a 20% discount the page says is auto-applied. The pre-discount figure on the page is $111.25. No checkout code is printed. Medication is included. Price source · checked 26 October 2026 |
| #3 SnagRX | $99compounded (not FDA-approved), checked 26 October 2026 a month, continuing Visit provider Affiliate link · we may earn a commission | Compounded semaglutide injection · Weekly subcutaneous injection · medication includedPrice source · checked 26 October 2026 |
| #4 Trimi | $99compounded (not FDA-approved), checked 26 October 2026 a month, continuing Visit provider | Compounded Semaglutide · Weekly injection · medication included New-patient price on the sale page, same at every prescribed dose. Monthly billing renews unless renewal is turned off. The 3-month prepaid plan is separate and is not this continuing price. The treatment page and cost guide still show an older schedule: $175 a month, or $99 a month when $1,188 is paid for 12 months. That older schedule is not this row. Compounded, not FDA-approved. Existing patients keep their earlier terms. Price source · checked 26 October 2026 |
| #5 Oak Longevity | $119compounded (not FDA-approved), checked 27 October 2026 a month, continuing Visit provider Affiliate link · we may earn a commission | Compounded GLP-1 · Weekly semaglutide injection · medication included Homepage still prints GLP-1 treatments for weight loss from $119/mo. The same homepage also says prescription weight loss from $108/mo. Checked 27 October 2026. The weight-loss page's $190 sentence was not reopened. Price source · checked 27 October 2026 |
Showing the 5 lowest comparable published prices from 20 eligible providers. The complete comparison includes every current catalog row.
- bmiMD: $149/mo effective • $447 prepaid every 3 monthscompounded (not FDA-approved)Last checked 14 Sept 2026Medication included as published
- bmiMD: $129/mo effective • $774 prepaid every 6 monthscompounded (not FDA-approved)Last checked 14 Sept 2026Medication included as published
- Curex: $49 first month starting price; exact renewal quote after intakecompounded (not FDA-approved)Last checked 7 Oct 2026Medication included as published
Eligibility, prescribed quantity, state availability, pharmacy fulfillment, shipping, supplies, and follow-up can change the final cost. Unknown fields remain unknown.
NovoCare's Ozempic ladder is the manufacturer number
The Ozempic self-pay page opened 1 November 2026 is Novo Nordisk's own offer. Patients new to the Ozempic Savings Offer or to NovoCare home delivery pay $199 for each month of 0.25 mg and 0.5 mg. That intro covers two monthly fills through 31 December 2026. After it, the page lists $349 a month for 0.25 mg, 0.5 mg, or 1 mg, and $499 a month at 2 mg. One month is one box of one pen.
The same page lists Ozempic for use with diet and exercise to improve blood sugar in adults with type 2 diabetes, and it lists additional injection uses for cardiovascular and kidney risk in defined groups of adults with type 2 diabetes. The $499 step is the 2 mg pen, not a second drug. Novo Nordisk says it can modify or cancel the offer.
Some telehealth pages quote a much higher brand card
Gala Health's Ozempic page, opened 1 November 2026, says From $1,299/month, cash price. It says insurance may reduce the cost. No other dollar was in the fetched text. That $1,299 is a program cash card for the brand. It is not the $199, $349, and $499 NovoCare ladder.
RxSpan MD's public product API, opened the same day, lists Ozempic at 1299 and leaves priceUnit empty. The stored catalog treats that 1299 as a monthly figure from an earlier check. This recheck did not find a billing period on the row, so the 1299 stays an unlabeled API price. The same API lists Wegovy at 1349 with priceUnit Month. Wegovy is a different product and is not Embody.
Embody's number is a compounded one-month price
Embody's compounded semaglutide product JSON, opened 1 November 2026, lists a sale price of $79 and a compare-at regular price of $299. The variant has no selling plan. The tirzepatide one-month JSON lists $129 and $349 the same way. The ledger price guide opened the same day still says Last verified 27 October 2026 and prints those four figures. The November read did not move them.
The sale is what the product JSON offers as the current price against the regular price. The page does not publish a selling plan that would turn $79 into the later month, and this ledger does not record the sale as the continuing price. A budget that can pay $79 once and a budget that can pay $299 on the regular price are different plans. Tirzepatide at Embody is the $129 sale and the $349 regular price, still a compounded product, still not an Ozempic pen.
Why the gap is not one discount
NovoCare's pharmacy page says its GLP-1 medicines are FDA-approved and that compound semaglutides are not. Subtracting Embody's $79 sale from Gala's $1,299, or from NovoCare's $349, treats three offers as one product. They are not. The Ozempic pen has a manufacturer, a dose ladder, and a labeled use. Embody's row is a compounded one-month supply with a sale price and a regular price.
A reader comparing continuing cost uses Embody's $299 regular price for semaglutide, not the $79 sale, and uses the NovoCare price for the dose in question: $349 after the intro for 0.25 mg, 0.5 mg, and 1 mg, or $499 at 2 mg. Gala's $1,299 a month is the cash card on that provider's page, useful when the question is what a telehealth brand listing prints, and separate from NovoCare.
Compounded semaglutide is not Ozempic. A lower compounded sale is not a coupon on the pen.
Where to confirm the next charge
The Ozempic cost note on this site walks the NovoCare ladder, the savings offer, and the dose step in more detail. The Embody price guide repeats the sale and the regular price with the 27 October 2026 verified line. The price module on this page lists current catalog rows for Ozempic and for compounded semaglutide, including the check date stored on each row.
Visit Embody at the top of this page uses /go/embody, which redirected to the issued Katalys offer on 1 November 2026. Visit Affinity Direct uses /go/affinity-direct. There is no /go hop for the Ozempic pen. A NovoCare price is confirmed on NovoCare. An Embody total is confirmed on Embody's product page before checkout.
What a budget line leaves with the prescriber
The Ozempic page lists type 2 diabetes uses. Embody's product is a compounded program titled for GLP-1 weight care. Which of those, if either, fits a person is a prescribing decision. The dollars only say what the opened pages charged.
If the question is which published bill is smaller, name the bill. NovoCare after the intro is $349 or $499 by dose. Gala's brand card is from $1,299 a month. Embody's regular compounded semaglutide price is $299, and the $79 sale is not that continuing price. Affinity Direct's 4-week compounded prices are a different provider and are compared with Embody on the pair page.
Common questions
- Is Embody an Ozempic pharmacy?
- No. Ozempic is Novo Nordisk's product. Embody's one-month product opened 1 November 2026 is titled Compounded Semaglutide (GLP-1), with a $79 sale and a $299 regular price. NovoCare's pharmacy page says compound semaglutides are not the FDA-approved medicines.
- Is Embody's $79 the price that continues?
- No. The product JSON labels $79 as the sale price and $299 as the regular price, and it has no selling plan. The sale is not the continuing price. Tirzepatide on the same read is a $129 sale and a $349 regular price.
- What did Ozempic cost without a telehealth card on 1 November 2026?
- On NovoCare, $199 a month for two fills of 0.25 mg and 0.5 mg through 31 December 2026, then $349 a month for 0.25 mg, 0.5 mg, or 1 mg, and $499 a month at 2 mg. Gala's separate cash card says from $1,299 a month. Those are different offers.
- Is there an Ozempic visit link here?
- No hop was issued for the Ozempic pen. Visit Embody at the top of this page uses /go/embody. Visit Affinity Direct uses /go/affinity-direct. Confirm NovoCare prices on the NovoCare page linked in the sources.
- How does Affinity Direct fit a budget that started with Embody?
- Affinity Direct is another compounded provider, not Ozempic. Its 1 mg semaglutide auto-refill is $152.15 every 4 weeks, rechecked 1 November 2026. That 4-week charge is compared with Embody's one-month sale and regular price on the Embody versus Affinity Direct page.
Price the pen and the compounded plan separately
Opened 1 November 2026, NovoCare's Ozempic pen is $199 for two fills, then $349 a month, and $499 a month at 2 mg. Gala lists the brand from $1,299 a month cash. Embody's compounded semaglutide is a $79 one-month sale against a $299 regular price, with no selling plan, and the sale is not the continuing price. Ozempic is the drug. Embody is the provider. The smaller number is not a discount on the other product.
Already on a ozempic plan? See which of 3 providers charge less than yours
Starting from scratch? How to get Ozempic injection online
Sources
- Ozempic self-pay offerNovo Nordisk · Accessed 1 November 2026
Opened 1 November 2026. Patients new to the Ozempic Savings Offer or NovoCare home delivery pay $199 for each month of 0.25 mg and 0.5 mg, for two monthly fills through 31 December 2026, then $349 a month for 0.25 mg, 0.5 mg, or 1 mg, and $499 a month for 2 mg. One month is one box of one pen. The page lists Ozempic injection and tablets for use with diet and exercise to improve blood sugar in adults with type 2 diabetes. It also lists injection uses for cardiovascular risk in adults with type 2 diabetes and known heart disease, and for kidney outcomes in adults with type 2 diabetes and chronic kidney disease. Novo Nordisk says it can modify or cancel the program.
- Gala Health Ozempic pageGala Health · Accessed 1 November 2026
Opened 1 November 2026. The page says From $1,299/month, cash price, and that insurance may reduce the cost. That was the only dollar price in the fetched text.
- RxSpan MD public product APIRxSpan MD · Accessed 1 November 2026
Opened 1 November 2026. The visible Ozempic row lists price 1299 and an empty priceUnit. The visible Wegovy row lists price 1349 and priceUnit Month. Neither row is a NovoCare self-pay ladder.
- Embody compounded semaglutide, one-month productEmbody · Accessed 1 November 2026
Opened 1 November 2026. The Shopify product JSON lists price 7900 and compare_at_price 29900, which is a $79 sale and a $299 regular price. The variant's selling_plan_allocations list is empty, and requires_selling_plan is false. The product title is Compounded Semaglutide (GLP-1).
- Embody compounded tirzepatide, one-month productEmbody · Accessed 1 November 2026
Opened 1 November 2026. The Shopify product JSON lists price 12900 and compare_at_price 34900, which is a $129 sale and a $349 regular price. The variant has no selling plan. The product title is Compounded Tirzepatide (GLP-1/GIP).
- Embody price guideTelehealth Ledger · Accessed 1 November 2026
Opened 1 November 2026. The page title says updated 27 October 2026, and the page says Last verified 27 October 2026. It prints compounded semaglutide at a $299 regular price and a $79 one-month sale, and compounded tirzepatide at a $349 regular price and a $129 one-month sale.
- NovoCare pharmacyNovo Nordisk · Accessed 1 November 2026
Opened 1 November 2026. The page says Novo Nordisk's GLP-1 medicines are FDA-approved and that compound semaglutides are not. It says every dose of Wegovy and Ozempic requires a prescription, whether the patient self-pays or uses insurance.
Refresh triggers
- NovoCare change to the Ozempic self-pay ladder or the 31 December 2026 intro window
- Gala or RxSpan change to the published Ozempic cash figure or its billing period
- Embody sale, regular price, or selling-plan change on the one-month semaglutide product